文献速递母胎医学产科

超声短股骨胎儿的遗传异常产前诊断:前瞻性队列研究

Prenatal diagnosis of genetic aberrations in fetuses with short femur detected by ultrasound: A prospective cohort study.
PubMed 文献 · Prenat Diagn · 2021-07-06

这项为期5年的前瞻性队列研究纳入161例短股骨单胎妊娠,均接受羊膜腔穿刺、SNP array及FGFR3 G380R突变Sanger测序。总体遗传异常率为16.2%(26/161),其中染色体异常占65.4%(17/26),G380R突变占34.6%(9/26)。股骨缩短程度不同对应不同遗传异常,FL低于孕龄2-4SD者SNP array应作为一线检测。

要点

  • 短股骨胎儿总体遗传异常率为16.2%,以染色体异常为主。
  • FL低于孕龄2-4SD者染色体异常风险更高,SNP array应作为一线检测。
  • FL低于-4SD者FGFR3 G380R突变检出显著更多。

核心结论

  • 不同股骨缩短程度可能对应不同遗传异常。
  • FL低于孕龄2-4SD的胎儿SNP array应作为一线检测。
  • FL低于孕龄2-4SD的胎儿预后显著优于FL低于4SD者。

研究设计与样本

  • 为期5年的前瞻性队列研究。
  • 纳入同意羊膜腔穿刺及SNP array和FGFR3 G380R突变Sanger测序的短股骨单胎妊娠,共161例。
  • 出生后进行临床随访评估。

主要发现

  • 161例中遗传异常患病率为16.2%(26/161)。
  • 26例遗传异常中染色体异常占65.4%(17/26),G380R突变占34.6%(9/26)。
  • 所有染色体异常胎儿的FL均低于孕龄2-4SD。
  • 孕晚期出现的短股骨胎儿中检出染色体异常较少。
  • FL低于-4SD的胎儿中检出FGFR3突变显著更多。

临床怎么用

  • 对短股骨胎儿应评估股骨缩短程度以指导遗传检测选择。
  • FL低于孕龄2-4SD时优先选择SNP array作为一线检测。
  • FL低于-4SD时应注意FGFR3 G380R突变检测。

局限性

  • 作者自述为小队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the genetic aberrations in fetuses with short femur and explore the relationships with respect to degree of femoral shortening and the initial diagnostic gestational age GA. METHODS: Singleton pregnancies with fetal short femur who consented to amniocentesis and to single nucleotide polymorphism (SNP) array and Sanger sequencing for G380R mutations in FGFR3 gene were enrolled in this 5-year period prospective study. Clinical follow-up assessments were performed after birth. RESULTS: Of a total of 161 fetuses, the prevalence of genetic aberrations was 16.2% (26/161), comprised of 65.4% (17/26) with chromosomal abnormalities and 34.6% (9/26) with G380R mutations. All fetuses with chromosomal abnormalities had FL 2-4SDs below GA. Fewer chromosomal abnormalities were detected in fetuses with short femurs presenting in the third trimester. Significantly more FGFR3 mutations were detected in fetuses with FL below -4SDs. All fetuses with FL 2-4SDs below GA diagnosed as achondroplasia were between 22 and 24 gestational weeks, and all of those diagnosed in third trimester had FL below -4SDs. CONCLUSION: In this small cohort study, we demonstrated that different degrees of femur shortness may be attributed to different genetic aberrations. SNP array should be regarded as the first-tier test for fetuses with FL 2-4SDs below GA. The prognoses for fetuses with FL 2-4SDs below GA was significantly better than those with FL below 4SDs.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Li Q, Zhang Z, Wang J, et al. Prenatal diagnosis of genetic aberrations in fetuses with short femur detected by ultrasound: A prospective cohort study. Prenat Diagn. 2021. PMID: 34185917. doi:10.1002/pd.6006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。